-
公开(公告)号:US09963452B2
公开(公告)日:2018-05-08
申请号:US14775825
申请日:2014-03-13
申请人: Dorre A. Grueneberg , Ori Kalid , Jun Xian , Sharanappa B. Rajur , Hwa-Ok Kim , Venugopal Rao Neelagiri , Paresh Salgaonkar , Divakaramenon Sethumadhavan , Chaeho Moon , Madhavi Neelagiri
发明人: Dorre A. Grueneberg , Ori Kalid , Jun Xian , Sharanappa B. Rajur , Hwa-Ok Kim , Venugopal Rao Neelagiri , Paresh Salgaonkar , Divakaramenon Sethumadhavan , Chaeho Moon , Madhavi Neelagiri
IPC分类号: A61K31/505 , A61K31/53 , C07D487/04 , A61K45/06 , A61K31/404 , A61K31/4375 , A61K31/454 , A61K31/497 , A61K31/506 , A61K31/519 , A61K31/551 , C07D209/08 , C07D243/14 , C07D401/14 , C07D403/12 , C07D409/14 , C07D417/12 , C07D417/14 , C07D471/04 , A61K31/194 , A61K31/437 , A61K31/452 , A61K31/4545
CPC分类号: C07D487/04 , A61K31/194 , A61K31/404 , A61K31/437 , A61K31/4375 , A61K31/452 , A61K31/454 , A61K31/4545 , A61K31/497 , A61K31/506 , A61K31/519 , A61K31/53 , A61K31/551 , A61K45/06 , C07D209/08 , C07D243/14 , C07D401/14 , C07D403/12 , C07D409/14 , C07D417/12 , C07D417/14 , C07D471/04 , A61K2300/00
摘要: The present invention relates to a method using some novel compounds and compositions for the inhibition of ROS tyrosine kinase. In particular, the present invention covers a method to treat abnormal cell growth, such as cancer, with ROS 10 inhibitors and compositions having ROS inhibitors. An illustrative compound of the invention is shown below Formula (I).
-
公开(公告)号:US20100184749A1
公开(公告)日:2010-07-22
申请号:US12445149
申请日:2007-10-12
申请人: Merav Fichman , Rosa E. Melendez , Pradyumna Mohanty , Jian Lin , Dilara McCauley , Boaz Inbal , Mercedes Lobera , Pini Orbach , Ori Kalid , Dongli Chen , Yael Marantz , Michael Xie , Sharon Shacham , Oren Becker
发明人: Merav Fichman , Rosa E. Melendez , Pradyumna Mohanty , Jian Lin , Dilara McCauley , Boaz Inbal , Mercedes Lobera , Pini Orbach , Ori Kalid , Dongli Chen , Yael Marantz , Michael Xie , Sharon Shacham , Oren Becker
IPC分类号: A61K31/549 , C07D417/06 , A61P37/06 , A61P17/06 , A61P19/02 , A61P9/10 , A61P11/00 , A61P13/12 , A61P1/16 , A61P3/10
CPC分类号: C07D285/16
摘要: Chemokine receptor antagonists, in particular, compounds of Formula (I) that act as antagonists of the chemokine CCR2 receptor, including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leukocyte accumulation are described herein.
摘要翻译: 本文描述了趋化因子受体拮抗剂,特别是作为趋化因子CCR2受体的拮抗剂的式(I)化合物,包括药物组合物及其用于治疗或预防与单核细胞积聚,淋巴细胞积聚或白细胞积聚相关的疾病的用途。
-